The Frictionless Enterprise: How an Ophthalmology CEO Can Drive Operational Excellence.
Build Redundancy Into the Supply Chain—and Own the Critical Steps Ophthalmic products depend on specialized inputs: medical-grade optics and polymers, precision lasers and sensors, sterile injectables and surgical packs. A single-source dependency anywhere in that chain is a dormant impediment waiting for a geopolitical shock, a port closure, or a supplier’s bankruptcy to activate it—advisors…
Read More
Paradise Lost: What Could Have Been, and What We Can Still Learn. Part 2.
3. Expand Distribution – VISX joins forces with Allergan Surgical VISX makes a formal offer to acquire Allergan’s Surgical division several years before it is spun out as AMO. Given the pressure from activist investor Carl Icahn, management is replaced and led by longtime Allergan executive Jim Mazzo, who is appointed CEO. This merger/acquisition would…
Read More 
